Fluconazole and voriconazole resistance in Candida parapsilosis is conferred by gain-of-function mutations in MRR1 transcription factor gene

Joana Branco, Ana P. Silva, Raquel M. Silva, Ana Silva-Dias, Cidália Pina-Vaz, Geraldine Butler, Acácio G. Rodrigues, Isabel M. Miranda*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

Candida parapsilosis is the second most prevalent fungal agent causing bloodstream infections. Nevertheless, there is little information about the molecular mechanisms underlying azole resistance in this species. Mutations (G1747A, A2619C, and A3191C) in the MRR1 transcription factor gene were identified in fluconazole-and voriconazole-resistant strains. Independent expression of MRR1 genes harboring these mutations showed that G1747A (G583R) and A2619C (K873N) are gain-of-function mutations responsible for azole resistance, the first described in C. parapsilosis.
Original languageEnglish
Pages (from-to)6629-6633
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume59
Issue number10
DOIs
Publication statusPublished - 1 Oct 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Fluconazole and voriconazole resistance in Candida parapsilosis is conferred by gain-of-function mutations in MRR1 transcription factor gene'. Together they form a unique fingerprint.

Cite this